Dissecting Immunotherapy Options for TNBC
Margaret Gatti-Mays MD, MPH, of The James Cancer Hospital at Ohio State University, discusses the available immunotherapy options in triple-negative breast cancer.
Margaret Gatti-Mays MD, MPH, of The James Cancer Hospital at Ohio State University, discusses the available immunotherapy options in triple-negative breast cancer.
Background Despite the well-known prognostic role of lymph node metastasis (LNM) in pNETs, less is known about the importance of lymphovascular invasion (LVI) among patients…
Hear Alan P. Venook, MD, discuss recent updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for gastrointestinal cancers.
Jairam Krishnamurthy, MD, FACP, discusses the selective use of CDK4/6 inhibitors after prior progression on these agents in patients with breast cancer.
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
Watch high school sports and events nationwide, live and on demand, via the NFHS Network. Stream regular season and playoffs online from anywhere.
The OncoAlert Newsletter is now out for June 23-29, 2023
In this 3-part educational series, explore the challenges of providing patient-centered care for multiple myeloma in community practices. Gain insights into effective strategies and solutions.
The head of NASA said a report that Elon Musk has been in regular contact with Russian President Vladimir Putin should be investigated — and…
Twitter and Tesla CEO Elon Musk has been subpoenaed for documents by the U.S. Virgin Islands in its case against JPMorgan Chase Bank in connection…